|
| Trial year prevention/treatment (reference) | Number of patients
(treatment/control) | Intervention | Duration | Outcomes measured |
|
|
Dai and Shen 2007 [10] | 107 versus 85 | MGT 1.5 g/dayXLGB 1.5 g/day versus placebo, all: (calcium 1000 mg/day) | 6 M | BMD: lumber spine and femoral neck |
|
Leung et al. 2011 [17] | 75 versus 75 | ELP 2.28 g/day versus placebo | 12 M | BMD: lumber spine and femoral neck |
|
Wu et al. 2009 [20] | 25 versus 25 | XLGB 1.5 g/day versus Calcitriol 0.25 g +
calcium 700 mg/day + vitamin D400 IU/day | 6 M | BMD: lumber spine and femoral neck |
|
Zhang et al. 2005 [11] | 67 versus 66
versus 60 | YGC 120 g/day versus Calcitriol 0.25 g versus placebo, all: (calcium 510 mg/day) | 6 M | BMD: lumber spine and femoral neck |
|
Ruan et al. 2006 [21] | 48 versus 42 | QGJN 0.75 g/day versus oral estradiol valerate 0.5–1.5 mg/day | 6 M | BMD: lumber spine |
|
Zhu et al. 2012 [12] | 109 versus 61 | XLGB 6 g/day versus placebo | 12 M | BMD: lumber spine and femoral neck |
|
Xiong et al. 2008 [13] | 73 versus 35 | JGKL 10 g/day versus placebo, all: (calcium 510 mg/day) | 6 M | BMD: lumber spine and femoral neck |
|
Zhou et al. 2009 [14] | 355 versus 119 | MGT 1.5 g/day versus XLGB 1.5 g/day | 6 M | BMD: lumber spine and femoral |
|
Liao et al. 2004 [15] | 32 versus 34 | BSSS soup 200 mL/day versus oral conjugated estrogen 0.5 mg/d and medroxyprogesterone 2.5 mg/d | 6 M | BMD: lumber spine and femoral |
|
Yang et al. 2007 [16] | 120 versus 120 | XLGB 1.5 g/day versus GKKFY 20 mL/day | 6 M | BMD: lumber spine and femoral neck |
|
Wang et al. 2006 [18] | 105 versus 105 | GSKC 2.56 g/day versus GSKT 20 g/day | 6 M | BMD: femoral neck |
|
Zheng et al. 2007 [19] | 55 versus 54 | JWGT 3 g/day versus placebo, all: (calcium 510 mg/day) | 6 M | BMD: lumber spine and hip |
|
